Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Medical University - Sofia, Sofia

Military Medical Academy - Sofia, Sofia

Transport Hospital, Sofia

"MBAL Stara Zagora EAD", Stara Zagora

Thalassotherapia, Opatija

KBC Osijek Ambulanta za bol, Osijek

University Hospital Centre Zagreb, Zagreb

University Hospital U Sv.Anny, Brno

Institute of Rheumatology, Prague

Rheumatology Out-patient Department, Prague

SZZ-Jizni Mesto II, Prague

University Hospital Kralovske Vinohrady, Prague

Szpital Specjalistyczny Nr 1, Bytom

Wojewodzki Szpital Zespolony, Elblag

Malopolskie Centrum Medyczne, Krakow

"Gabinety Profesorow Prywatna Praktyka", Lublin

Instytut Medycyny Wsi im. Witolda Chodzki, Lublin

Wojewodzki Zespoￅﾂ Reumatologiczny im., Sopot

"NZOZ Nasz Lekarz Praktyka Grupowa Lekarzy", Torun

Okregowy Szpital Kolejowy, Wroclaw

ZOZ Zyrardow, Żyrardów

Pirogov City Clinical Hospital #1, Moscow

State Institute of Rheumatology of RAMS, Moscow

State Clinical Immunology Research, Novosibirsk

Ryazan Regional Clinical Cardiologic, Ryazan

City Pokrovskaya Hospital, Saint Petersburg

EVIDENCE Clinical and Pharmaceutical Research, Saint Petersburg

Leningrad Regional Hospital, Saint Petersburg

Saint Petersburg Clinical Hospital, Saint Petersburg

Saint-Petersburg City Hospital, Saint Petersburg

Saint-Petersburg Medical Academy, Saint Petersburg

Saratov Regional Clinical Hospital, Saratov

Institute of Rheumatology, Beograd

Institute of Rheumatology - Niska Banja, Niska Banja

Clinical Center Zemun, Zemun

National Institute of Rheumatic Diseases, Piešťany

Clinical Center Ljubljana, Ljubljana

Dniepropetrovsk State Medical Academy, Dniepropetrovsk

Donetsk State Medical University, Donetsk

Institute of Cardiology of Ukranian AMS, Kiev

Institute of Gerontology of Ukrainian AMS, Kiev

SanaClis s.r.o., Kiev

Zaporizhya Medical Institute, Zaporizhya